Kerma Systems Research 

Measurement and prediction of the dose received by an organ due to radiotherapy treatment to reduce side effects.


María del Carmen Ovejero Mayoral (See Profile)


Maria José Huertas (See Profile)


Cancer therapeutics


Development, market readiness, clinical trial



Kerma measures and predicts the effective dose received by an organ due to radiotherapy treatment to reduce side effects

The Proprietary Technology used is able to provide the correct dose for each patient

Kerma also provides a Service which allows to the Hospitals connected to its server an improved dose delivered

IP Type Status Time Countries Link Coverage
Patent Approved 15 years
  • Austria
  • Belgium
  • Canada
  • China
  • Denmark
  • Finland
  • France
  • Germany
  • Italy
  • Japan
  • Netherlands
  • Spain
  • USA It protects an invention which relates to a method for the automation and integration, in a single environment, of the analysis of the beam of an accelerator, as well as the verification of a radiotherapy treatment and remote control thereof, the method being based on the use of a detection means situated on a mannequin (planar, cylindrical or anthropomorphic) and formed by a plurality of semiconductor detectors segmented into strips or pixels, preferably made from silicon and located in a bunker.

This information is confidential, do not share or copy.

Under evaluation at least till: 20th May

If you want to have more information or you want to review the project, you have to login or register


©2022 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

Aviso de cookies

Log in with your credentials


Forgot your details?

Create Account

Skip to toolbar